Abstract
Neurotransmitters catechol and dopamine analogy levels are related to the systematic nerve activity. This assay was performed by using cyclic voltammetry (CV) and square wave (SW) stripping voltammetry, while optimization was performed by the carbon fiber microelectrode (CFME) with wire-type reference and counter electrodes. In the electrolyte solutions, the analytical parameters of catechol were as follows: 8.5 pH, -0.4 V anodic, 0.3 V cathodic, 15s deposition time, 15 Hz SW frequency, 25 mV SW amplitude and incremental potential of 4 mV, under optimal conditions, working ranges were 0-50 mgL-1 CV, 0.01-50 mgL-1 cathodic, and 1-13 mgL-1 anodic, the relative standard deviation was 0.02 %, n = 15 using 0.5 mgL-1 and the detection limit was 4.0 ugL-1. It can be used for in vivo direct analysis. Here, diagnostic applications were performed in the brain skeleton of living cells in real time. The developed techniques can be useful for nerve control and signal detections.
Keywords: Brain, catechol, dopamine, epinephrine, live fish, micro carbon fiber, skeleton, voltammetry
Current Neurovascular Research
Title: Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System
Volume: 7 Issue: 1
Author(s): Suw Young Ly, Hwa Jin Heo and Min Jung Kim
Affiliation:
Keywords: Brain, catechol, dopamine, epinephrine, live fish, micro carbon fiber, skeleton, voltammetry
Abstract: Neurotransmitters catechol and dopamine analogy levels are related to the systematic nerve activity. This assay was performed by using cyclic voltammetry (CV) and square wave (SW) stripping voltammetry, while optimization was performed by the carbon fiber microelectrode (CFME) with wire-type reference and counter electrodes. In the electrolyte solutions, the analytical parameters of catechol were as follows: 8.5 pH, -0.4 V anodic, 0.3 V cathodic, 15s deposition time, 15 Hz SW frequency, 25 mV SW amplitude and incremental potential of 4 mV, under optimal conditions, working ranges were 0-50 mgL-1 CV, 0.01-50 mgL-1 cathodic, and 1-13 mgL-1 anodic, the relative standard deviation was 0.02 %, n = 15 using 0.5 mgL-1 and the detection limit was 4.0 ugL-1. It can be used for in vivo direct analysis. Here, diagnostic applications were performed in the brain skeleton of living cells in real time. The developed techniques can be useful for nerve control and signal detections.
Export Options
About this article
Cite this article as:
Ly Young Suw, Heo Jin Hwa and Kim Jung Min, Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System, Current Neurovascular Research 2010; 7 (1) . https://dx.doi.org/10.2174/156720210790820154
DOI https://dx.doi.org/10.2174/156720210790820154 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurotransmitters and Substances of Abuse: Effects on Adult Neurogenesis
Current Neurovascular Research Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Editorial
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Half a Century of l-DOPA
Current Topics in Medicinal Chemistry Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Current Pharmaceutical Design Neurotoxicity by Synthetic Androgen Steroids: Oxidative Stress, Apoptosis, and Neuropathology: A Review
Current Neuropharmacology Animal Models for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Development of ATP13A2-deficient In vitro Model for PARK9 Parkinson’s Disease
Current Signal Transduction Therapy Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide
Protein & Peptide Letters Beneficial Neurobiological Effects of Melatonin Under Conditions of Increased Oxidative Stress
Current Medicinal Chemistry - Central Nervous System Agents Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review
Current Pharmaceutical Design Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets Use of Radiopharmaceuticals for Diagnosis, Treatment, and Follow-Up of Differentiated Thyroid Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Current Pharmaceutical Design Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Current Drug Targets Glial Cells – The Key Elements of Alzheimer´s Disease
Current Alzheimer Research Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design Patents Related to Cancer Stem Cell Research
Recent Patents on DNA & Gene Sequences Vaccine Ingredients: Components that Influence Vaccine Efficacy
Mini-Reviews in Medicinal Chemistry